Radical vulvectomy for invasive squamous cell carcinoma of the vulva

Author(s): Boutselis JG

Abstract

During a 12 year period, 102 patients with invasive epidermoid carcinoma of the vulva were treated at the University of Iowa Hospitals and Clinic. The over-all corrected three year survival rate was 65.5 per cent, or 67 of 102 patients. Those treated by radical vulvectomy and bilateral dissection of groin nodes had a three year survival rate of 76.9 per cent, or 40 of 52 patients, while those treated by radiotherapy had a survival rate of 10 per cent, or two of 20 patients. Those with Stage I disease lesions, less than 1 centimeter in diameter, had an excellent survival rate whether they were treated by vulvectomy only or by radical vulvectomy with groin node dissection. Our experience in this selected group of patients would indicate that a degree of individualization in the treatment of early invasive lesions of the vulva can give most satisfactory results.

Similar Articles

Trends in the incidence of invasive and in situ vulvar carcinoma

Author(s): Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA

New aspects of vulvar cancer: changes in localization and age of onset

Author(s): Hampl M, Deckers-Figiel S, Hampl JA, Rein D, Bender HG

The impact of improving outcomes guidance on surgical management of vulval squamous cell cancer in southwest England (1997-2002)

Author(s): Falconer AD, Hirschowitz L, Weeks J, Murdoch J; South West Gynaecology Tumour Panel

Groin dissection practices among gynecologic oncologists treating early vulvar cancer

Author(s): Levenback C, Morris M, Burke TW, Gershenson DM, Wolf JK, et al.

A proposed glossary of terminology related to the surgical treatment of vulvar carcinoma

Author(s): Micheletti L, Preti M, Zola P, Zanotto Valentino MC, Bocci C, et al.

FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers

Author(s): Benedet JL, Bender H, Jones H 3rd, Ngan HY, Pecorelli S

Carcinoma of the vulva

Author(s): Rutledge F, Smith JP, Franklin EW

Squamous carcinoma of the vulva: results of treatment, 1938 to 1976

Author(s): Benedet JL, Turko M, Fairey RN, Boyes DA

Changing trends in the surgical treatment of invasive carcinoma of the vulva

Author(s): Cavanagh D, Roberts WS, Bryson SC, Marsden DE, Ingram JM, et al.

Management of regional lymph nodes and their prognostic influence in vulvar cancer

Author(s): Hacker NF, Berek JS, Lagasse LD, Leuchter RS, Moore JG

Squamous vulvar cancer: a clinically based individualization of treatment

Author(s): Rodolakis A, Diakomanolis E, Voulgaris Z, Akrivos T, Vlachos G, et al.

Clinical and pathological prognostic factors in squamous cell carcinoma of the vulva

Author(s): Raspagliesi F, Hanozet F, Ditto A, Solima E, Zanaboni F, et al.

Carcinoma of the vulva

Author(s): Beller U, Quinn MA, Benedet JL, Creasman WT, Ngan HY

Changes in the management of vulval cancer

Author(s): Dhar KK, Woolas RP

Individualization of treatment for stage I squamous cell vulvar carcinoma

Author(s): Hacker NF, Berek JS, Lagasse LD, Nieberg RK, Leuchter RS